Armin Soave
Priv.-Doz. Dr. med.
Armin Soave
FEBU FECSM EAA
  • Oberarzt
  • Facharzt für Urologie
  • Andrologie
  • Sexualmedizin
Arbeitsbereich

Kontakt

Standort

Hauptgebäude O10 , 2. Etage
Sprachen
Deutsch (Muttersprache)
Italienisch
Englisch

Fachgebiete

Tätigkeitsschwerpunkte

Publikationen

2021

Exploring the intersection of functional recurrence, patient-reported sexual function, and treatment satisfaction after anterior buccal mucosal graft urethroplasty

WORLD J UROL. 2021;2021(doi: 10.1007/s00345-021-03648-y):.

Assessing the Outcome of Holmium Laser Enucleation of the Prostate by Age, Prostate Volume, and a History of Blood Thinning Agents
Gild P, Lenke L, Pompe R, Vetterlein M, Ludwig T, Soave A, Chun F, Ahyai S, Dahlem R, Fisch M, Rink M, Meyer C, Becker A
J ENDOUROL. 2021;2021(doi: 10.1089/end.2020.0605):.

Continence and Complication Rates of Artificial Urinary Sphincter Devices (AMS 800) for Parkinson and Stroke Patients with Incontinence after Prostate Surgery: Retrospective Analysis of a Prospective Database
Maurer V, Stahlberg J, Schiffmann I, Marks P, Rosenbaum C, Soave A, Vetterlein M, Meyer C, Riechardt S, Fisch M, Ludwig T, Dahlem R
UROL INT. 2021;105(3-4):225-231.

2020

Longitudinal Evaluation of Perineogenital Pain and Postoperative Complications After One-stage Buccal Mucosal Graft Urethroplasty: A Secondary Analysis of a Randomized Controlled Trial
Fuehner C, Vetterlein M, Lesske J, Rink M, Riechardt S, König F, Gild P, Pinnschmidt H, Meyer C, Ludwig T, Engel O, Fisch M, Dahlem R, Soave A
Eur Urol Focus. 2020.

Retrograde Ejaculation After Holmium Laser Enucleation Of The Prostate (HoLEP) - Impact On Sexual Function and Evaluation Of Patient Bother Using Validated Questionnaires
Gild P, Dahlem R, Pompe R, Soave A, Vetterlein M, Ludwig T, Maurer V, Marks P, Ahyai S, Chun F, Lenke L, Ernst T, Fisch M, Rink M, Meyer C, Becker A
ANDROLOGY-US. 2020;8(6):1779-1786.

Impact of Cardiovascular and Metabolic Risk Factors on Stricture Recurrence After Anterior One-stage Buccal Mucosal Graft Urethroplasty
Meyer C, Lamp J, Vetterlein M, Soave A, Engel O, Dahlem R, Fisch M, Kluth L
UROLOGY. 2020;146:253-259.

Clinical Recommendations From the European Society for Sexual Medicine Exploring Partner Expectations, Satisfaction in Male and Phalloplasty Cohorts, the Impact of Penile Length, Girth and Implant Type, Reservoir Placement, and the Influence of Comorbidities and Social Circumstances
Osmonov D, Christopher A, Blecher G, Falcone M, Soave A, Dahlem R, Czeloth K, Bannowsky A, Matanes E, Ward S, Martínez-Salamanca J, Bettocchi C, Garaffa G, Reisman Y, Corona G
J SEX MED. 2020;17(2):210-237.

Copy number variations in primary tumor, serum and lymph node metastasis of bladder cancer patients treated with radical cystectomy
Soave A, Kluwe L, Yu H, Rink M, Gild P, Vetterlein M, Marks P, Sauter G, Fisch M, Meyer C, Ludwig T, Dahlem R, Minner S, Pantel K, Steinbach B, Schwarzenbach H
SCI REP-UK. 2020;10(1):21562.

Improving Estimates of Perioperative Morbidity After Radical Cystectomy Using the European Association of Urology Quality Criteria for Standardized Reporting and Introducing the Comprehensive Complication Index
Vetterlein M, Klemm J, Gild P, Bradtke M, Soave A, Dahlem R, Fisch M, Rink M
EUR UROL. 2020;77(1):55-65.

Buccal mucosal graft urethroplasty for radiation-induced urethral strictures: an evaluation using the extended Urethral Stricture Surgery Patient-Reported Outcome Measure (USS PROM)
Vetterlein M, Kluth L, Zumstein V, Meyer C, Ludwig T, Soave A, Riechardt S, Engel O, Dahlem R, Fisch M, Rosenbaum C
WORLD J UROL. 2020;38(11):2863-2872.

2019

Perioperative management of direct oral anticoagulants in patients undergoing radical prostatectomy: results of a prospective assessment
Beckmann A, Spalteholz J, Langer F, Heinzer H, Budäus L, Tilki D, Michl U, Soave A, Steuber T, Veleva V, Salomon G, Haese A, Huland H, Graefen M, Isbarn H
WORLD J UROL. 2019;37(12):2657-2662.

Do Younger Patients With Muscle-invasive Bladder Cancer Have Better Outcomes?
Janisch F, Yu H, Vetterlein M, Dahlem R, Engel O, Fisch M, Shariat S, Soave A, Rink M
J CLIN MED. 2019;8(9):.

The impact of variant histological differentiation on extranodal extension and survival in node positive bladder cancer treated with radical cystectomy
Marks P, Gild P, Soave A, Janisch F, Minner S, Engel O, Vetterlein M, Shariat S, Sauter G, Dahlem R, Fisch M, Rink M
SURG ONCOL. 2019;28:208-213.

The current role and future directions of circulating tumor cells and circulating tumor DNA in urothelial carcinoma of the bladder
Rink M, Schwarzenbach H, Riethdorf S, Soave A
WORLD J UROL. 2019;37(9):1785-1799.

The current role of circulating biomarkers in non-muscle invasive bladder cancer
Rink M, Schwarzenbach H, Vetterlein M, Riethdorf S, Soave A
Transl Androl Urol. 2019;8(1):61-75.

Outcome of buccal mucosa graft urethroplasty: a detailed analysis of success, morbidity and quality of life in a contemporary patient cohort at a referral center
Soave A, Kluth L, Dahlem R, Rohwer A, Rink M, Reiß C, Fisch M, Engel O
BMC Urol. 2019;19:.

Negative Self-Perception and Self-Attitude of Sexuality Is a Risk Factor for Patient Dissatisfaction Following Penile Surgery with Small Intestinal Submucosa Grafting for the Treatment of Severe Peyronie's Disease
Soave A, Laurich S, Dahlem R, Vetterlein M, Engel O, Nieder T, Briken P, Rink M, Fisch M, Reiss C
J CLIN MED. 2019;8(8):.

2018

Substitution Urethroplasty with Closure Versus Nonclosure of the Buccal Mucosa Graft Harvest Site: A Randomized Controlled Trial with a Detailed Analysis of Oral Pain and Morbidity
Soave A, Dahlem R, Pinnschmidt H, Rink M, Langetepe J, Engel O, Kluth L, Loechelt B, Reiss P, Ahyai S, Fisch M
EUR UROL. 2018;73(6):910-922.

Commentary on "Detection and oncological effect of circulating tumor cells in patients with variant urothelial carcinoma histology treated with radical cystectomy."
Soave A, Riethdorf S, Dahlem R, Minner S, Weisbach L, Engel O, Fisch M, Pantel K, Rink M
UROL ONCOL-SEMIN ORI. 2018;36(7):347-348.

Evaluating Guideline Adherence for T1 Bladder Cancer Treatment and Surveillance: A Retrospective German Multicenter Observation
Vetterlein M, Gild P, Marks P, Roschinski J, Doh O, Höppner W, Wagner W, Isbarn H, Büscheck F, Sauter G, Dahlem R, Soave A, Fisch M, Rink M
UROL INT. 2018;101(3):285-292.

Antigen-Specific IgG Subclasses in Primary and Malignancy-Associated Membranous Nephropathy
von Haxthausen F, Reinhard L, Pinnschmidt H, Rink M, Soave A, Hoxha E, Stahl R
FRONT IMMUNOL. 2018;9:3035.

2017

Immunohistochemical and serological characterization of membranous nephropathy in children and adolescents
Dettmar A, Wiech T, Kemper M, Soave A, Rink M, Oh J, Stahl R, Hoxha E
PEDIATR NEPHROL. 2017;33(3):463-472.

Retinal toxicity after cisplatin-based chemotherapy in patients with germ cell cancer
Dulz S, Asselborn N, Dieckmann K, Matthies C, Wagner W, Weidmann J, Seidel C, Oing C, Berger L, Alsdorf W, Mankichian B, Meyer C, Vetterlein M, Gild P, Ludwig T, Soave A, Schriefer P, Becker A, Ahyai S, Oechsle K, Bokemeyer C, Wagenfeld L, Fisch M, Hartmann M, Chun F, Kluth L
J CANCER RES CLIN. 2017;143(7):1319-1325.

The current status and clinical value of circulating tumor cells and circulating cell-free tumor DNA in bladder cancer
Riethdorf S, Soave A, Rink M
Transl Androl Urol. 2017;6(6):1090-1110.

The effect of AB0 and Rhesus blood grouping systems on oncological outcome in patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma
Rink M, Engel O, Gakis G, Fritsche H, Vetterlein M, Soave A, Peine S, Aziz A, Dahlem R, Stenzl A, Burger M, Shariat S, Fisch M, Gild P
UROL ONCOL-SEMIN ORI. 2017;35(12):671.e17-671.e23.

Copy number variations of circulating, cell-free DNA in urothelial carcinoma of the bladder patients treated with radical cystectomy: a prospective study
Soave A, Chun F, Hillebrand T, Rink M, Weisbach L, Steinbach B, Fisch M, Pantel K, Schwarzenbach H
ONCOTARGET. 2017;8(34):56398-56407.

Detection and oncological effect of circulating tumour cells in patients with variant urothelial carcinoma histology treated with radical cystectomy
Soave A, Riethdorf S, Dahlem R, Minner S, Weisbach L, Engel O, Fisch M, Pantel K, Rink M
BJU INT. 2017;119(6):854-861.

A nonrandomized, prospective, clinical study on the impact of circulating tumor cells on outcomes of urothelial carcinoma of the bladder patients treated with radical cystectomy with or without adjuvant chemotherapy
Soave A, Riethdorf S, Dahlem R, von Amsberg G, Minner S, Weisbach L, Engel O, Fisch M, Pantel K, Rink M
INT J CANCER. 2017;140(2):381-389.

Impact of the Ki-67 labeling index and p53 expression status on disease-free survival in pT1 urothelial carcinoma of the bladder
Vetterlein M, Roschinski J, Gild P, Marks P, Soave A, Doh O, Isbarn H, Höppner W, Wagner W, Shariat S, Brausi M, Büscheck F, Sauter G, Fisch M, Rink M
Transl Androl Urol. 2017;6(6):1018-1026.

2016

Outcomes of single- vs double-cuff artificial urinary sphincter insertion in low- and high-risk profile male patients with severe stress urinary incontinence.
Ahyai S, Ludwig T, Dahlem R, Soave A, Rosenbaum C, Chun F, Fisch M, Schmid M, Kluth L
BJU INT. 2016;118(4):625-32.

Infra- und supradiaphragmale Urethraverletzungen. Akute Therapie
Engel O, Boehm K, Rink M, Soave A, Fisch M
UROLOGE. 2016;55(4):475-8.

Psychometric validation of a German language version of a PROM for urethral stricture surgery and preliminary testing of supplementary ED and UI constructs
Kluth L, Dahlem R, Becker A, Schmid M, Soave A, Rosenbaum C, Ludwig T, Christ N, Rink M, Reiss P, Engel O, Riechardt S, Chun F, Fisch M, Ahyai S
WORLD J UROL. 2016;34(3):369-375.

Female with bladder cancer: what and why is there a difference?
Marks P, Soave A, Shariat S, Fajkovic H, Fisch M, Rink M
Transl Androl Urol. 2016;5(5):668-682.

Liquid biopsies in bladder cancer-did we find the Holy Grail for biomarker analyses?
Rink M, Shariat S, Soave A
Transl Androl Urol. 2016;5(6):980-983.

Re: Vinflunine in Routine Clinical Practice for the Treatment of Advanced or Metastatic Urothelial Cell Carcinoma-Data from a Prospective, Multicenter Experience
Soave A, Rink M
EUR UROL. 2016;69(2):373-4.

2015

Outcomes of Ventral Onlay Buccal Mucosa Graft Urethroplasty in Patients after Radiotherapy
Ahyai S, Schmid M, Kuhl M, Kluth L, Soave A, Riechardt S, Chun F, Engel O, Fisch M, Dahlem R
J UROLOGY. 2015;194(2):441-6.

The impact of the AB0 and the Rhesus blood group system on outcomes in bladder cancer patients treated with radical cystectomy
Engel O, Soave A, Peine S, Kluth L, Schmid M, Shariat S, Dahlem R, Fisch M, Rink M
WORLD J UROL. 2015;33(11):1769-1776.

"Tissue engineering" in der rekonstruktiven Urologie
Engel O, Soave A, Rink M, Dahlem R, Hellwinkel O, Chun F, Fisch M
UROLOGE. 2015;54(5):690-695.

Reconstructive management with urethroplasty.
Engel O, Soave A, Rink M, Fisch M
EUR UROL SUPPL. 2015;15(1):13-16.

Impact of Perioperative Allogenic Blood Transfusion on Survival After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma
Rink M, Soave A, Dahlem R, Aziz A, Al-Sayed F, Peine S, Engel O, Kluth L, Stenzl A, Burger M, Shariat S, Fisch M, Fritsche H, Gakis G
CLIN GENITOURIN CANC. 2015;14(1):96-104.

Management of advanced bladder cancer in the era of targeted therapies
Soave A, Engel O, von Amsberg G, Becker A, Dahlem R, Shariat S, Fisch M, Rink M
Minerva Urol Nefrol. 2015;67(2):103-15.

The Impact of Tumor Diameter and Tumor Necrosis on Oncologic Outcomes in Patients With Urothelial Carcinoma of the Bladder Treated With Radical Cystectomy
Soave A, John L, Dahlem R, Minner S, Engel O, Schmidt S, Kluth L, Fisch M, Rink M
UROLOGY. 2015;86(1):92-8.

Do circulating tumor cells have a role in deciding on adjuvant chemotherapy after radical cystectomy?
Soave A, Riethdorf S, Pantel K, Fisch M, Rink M
Curr Urol Rep. 2015;16(7):Art. 46.

Does the extent of variant histology affect oncological outcomes in patients with urothelial carcinoma of the bladder treated with radical cystectomy?
Soave A, Schmidt S, Dahlem R, Minner S, Engel O, Kluth L, John L, Hansen J, Schmid M, Sauter G, Shariat S, Fisch M, Rink M
UROL ONCOL-SEMIN ORI. 2015;33(1):21.e1-9.

2014

Prognostic relevance of postoperative platelet count in upper tract urothelial carcinoma after radical nephroureterectomy
Gakis G, Fritsche H, Hassan F, Kluth L, Miller F, Soave A, Otto W, Schwentner C, Todenhöfer T, Dahlem R, Burger M, Fisch M, Stenzl A, Aziz A, Rink M
EUR J CANCER. 2014;50(15):2583-2591.

Erratum zu: Detektion und Stellenwert von zirkulierenden Tumorzellen im peripheren Blut beim Urothelkarzinom der Harnblase
Rink M, Soave A, Engel O, Fisch M, Riethdorf S, Pantel K
UROLOGE. 2014;53(5):740.

Zirkulierende Tumorzellen im peripheren Blut beim Urothelkarzinom der Harnblase: Detektion und Stellenwert
Rink M, Soave A, Engel O, Fisch M, Riethdorf S, Pantel K
UROLOGE. 2014;53(4):501-508.

Contemporary gender-specific outcomes in Germany after radical cystectomy for bladder cancer
Schmid M, Shariat S, Soave A, Engel O, Fisch M, Rink M
Curr Urol Rep. 2014;15(6):409.

Gender-specific outcomes of bladder cancer patients: A stage-specific analysis in a contemporary, homogenous radical cystectomy cohort
Soave A, Dahlem R, Hansen J, Weisbach L, Minner S, Engel O, Kluth L, Chun F, Shariat S, Fisch M, Rink M
EJSO-EUR J SURG ONC. 2014;41(3):368-377.

Therapieoptionen der rezidivierenden oder persistierenden Belastungsharninkontinenz
Soave A, Engel O, Rink M, Fisch M, Dahlem R
UROLOGE. 2014;53(3):346-353.

Komplikationen bei Hypospadiekorrekturen
Soave A, Riechardt S, Engel O, Rink M, Fisch M
UROLOGE. 2014;53(7):1001-1005.

Epispadie-Ekstrophie-Komplex
Soave A, Rink M, Fisch M
2014. Facharztwissen Urologie: Differenzierte Diagnostik und Therapie. Schmelz H, Sparwasser C, Weidner W (Hrsg.). 3. Aufl. Springer, 359-362.

Hyospadie
Soave A, Rink M, Fisch M
2014. Facharztwissen Urologie: Differenzierte Diagnostik und Therapie. Schmelz H, Sparwasser C, Weidner W (Hrsg.). 3. Aufl. Springer, 353-358.

Harnröhrenklappen
Soave A, Rink M, Fisch M, Beetz R
2014. Facharztwissen Urologie: Differenzierte Diagnostik und Therapie. Schmelz H, Sparwasser C, Weidner W (Hrsg.). 3. Aufl. Springer, 363-366.

Histopathological Characteristics of Buccal Mucosa Transplants in Humans after Engraftment to the Urethra: A Prospective Study
Soave A, Steurer S, Dahlem R, Rink M, Reiss P, Fisch M, Engel O
J UROLOGY. 2014;192(6):1725-9.

MALDI imaging-based identification of prognostically relevant signals in bladder cancer using large-scale tissue microarrays
Steurer S, Singer J, Rink M, Chun F, Dahlem R, Simon R, Burandt E, Stahl P, Terracciano L, Schlomm T, Wagner W, Höppner W, Omidi M, Kraus O, Kwiatkowski M, Doh O, Fisch M, Soave A, Sauter G, Wurlitzer M, Schlüter H, Minner S
UROL ONCOL-SEMIN ORI. 2014;32(8):1225-33.

2013

Transperineal reanastomosis for the treatment for highly recurrent anastomotic strictures as a last option before urinary diversion
Reiß C, Pfalzgraf D, Kluth L, Soave A, Fisch M, Dahlem R
WORLD J UROL. 2013.

Lymph node dissection during radical cystectomy for bladder cancer treatment: considerations on relevance and extent
Weisbach L, Dahlem R, Simone G, Hansen J, Soave A, Engel O, Chun F, Shariat S, Fisch M, Rink M
INT UROL NEPHROL. 2013;45(6):1561-7.

2012

Prognostic role and HER2 expression of circulating tumor cells in peripheral blood of patients prior to radical cystectomy: a prospective study.
Rink M, Chun F, Dahlem R, Soave A, Minner S, Hansen J, Stoupiec M, Coith C, Kluth L, Ahyai S, Friedrich M, Shariat S, Fisch M, Pantel K, Riethdorf S
EUR UROL. 2012;61(4):810-817.

Inkontinenzmanagement beim orthotopen Blasenersatz
Soave A, Dahlem R, Rink M, Ahyai S, Fisch M
UROLOGE. 2012;51(4):494-9.

[Management of urinary incontinence after orthotopic urinary diversion].
Soave A, Dahlem R, Rink M, Ahyai S, Fisch M
UROLOGE. 2012;51(4):494-499.

Letzte Aktualisierung aus dem FIS: 12.05.2021 - 00:51 Uhr